We evaluated the role of [18F]FDG PET/CT in tumor response assessment and prognosis of Primary Extranodal Lymphoma (PEL) patients.
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis / Salvatore, B., Fonti, R., De Renzo, A., Pellegrino, S., Ferrara, I.L., Mainolfi, C.G., Marano, L., Selleri, C., Pane, F., Del Vecchio, S., Pace, L.. - In: THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1827-1936. - 64:2(2020), pp. 219-225. [10.23736/S1824-4785.18.03043-1]
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis
Fonti, Rosa;De Renzo, Amalia;Pellegrino, Sara;Ferrara, Ida L;Mainolfi, Ciro G;Marano, Luana;Selleri, Carmine;Pane, Fabrizio;Del Vecchio, Silvana;Pace, Leonardo
2020
Abstract
We evaluated the role of [18F]FDG PET/CT in tumor response assessment and prognosis of Primary Extranodal Lymphoma (PEL) patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
